BIVDA Press Releases

17Feb

Member Press Release - Revolutionise Your Pancreatic Elastase Testing with Alpha Labs

Revolutionise Your Pancreatic Elastase Testing with the New BÜHLMANN fPELA® turbo
Faecal pancreatic elastase testing can now be automated, providing flexible and random access application on most clinical chemistry platforms. The new fPELA® turbo from BÜHLMANN is ideal for use in laboratory environments for identification and monitoring of pancreatic insufficiency in patients. There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay, so it is possible to run both tests from a single extract.

The fPELA technology is a milestone in automation of pancreatic elastase quantification. It reduces the hands-on time dramatically and allows reporting of pancreatic elastase results from human stool samples within the shortest time. Time to first result is just 10 minutes with further results following every few seconds thereafter, making it one of the fastest faecal elastase assays available.

Please visit www.alphalabs.co.uk/fpela to find out more about the fPELA® turbo, or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk 

Related

Member Press Release - EKF opens larger facility to increase production of key component for COVID-19 testing regime

Cardiff, UK – 21st January 2021 – EKF Diagnostics, the global in vitro diagnostics compa...

Read More >

BIVDA Welcomes NICE Five Year Plan

BIVDA welcomes NICE Five Year Plan BIVDA, the trade association for British IVD companies, &nbs...

Read More >

BIVDA Press Release - BIVDA welcomes opening of Diagnostics Transformation Fund  

BIVDA, the trade association for British in-vitro diagnostic companies, has welcomed the launch of t...

Read More >

All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences.

Read More >

BIVDA comments on Parliament’s vote on the EU withdrawal agreement

Doris-Ann Williams, Chief Executive of BIVDA, comments on today's vote

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >